BioHealth News Archive

How Johns Hopkins’ coronavirus dashboard came to be – CNET

How Johns Hopkins’ coronavirus dashboard came to be – CNET

As COVID-19 became a growing concern around the world early last year, Lauren Gardner tapped into her research expertise as an infectious disease modeler.…

Read More
Amalgam Rx Appoints Medicare COO Jennifer Main as COO and CFO

Amalgam Rx Appoints Medicare COO Jennifer Main as COO and CFO

Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform, is announcing the appointment…

Read More
One Year In: Visualizing Key Events in the COVID-19 Timeline

One Year In: Visualizing Key Events in the COVID-19 Timeline

Visualized: Key Events in the COVID-19 Timeline It’s been a long and eventful year since COVID-19 was officially declared a global pandemic by the…

Read More
Startup Behind AstraZeneca Covid-19 Vaccine Raises $168 Million in Step Toward IPO – WSJ

Startup Behind AstraZeneca Covid-19 Vaccine Raises $168 Million in Step Toward IPO – WSJ

LONDON—The Oxford startup behind AstraZeneca PLC’s Covid-19 vaccine has raised $168 million in new funding, which it plans to use to adopt its vaccine…

Read More
8 recent health IT, innovation partnerships

8 recent health IT, innovation partnerships

Here are eight recent health IT vendor contracts and go-lives accelerating digital transformation efforts at healthcare organizations. 1. Highmark Health, the parent company of…

Read More

Biohealth Capital Fund Introductory Video

Read More
Sucampo founders’ VLP Therapeutics raises $16M – Washington Business Journal

Sucampo founders’ VLP Therapeutics raises $16M – Washington Business Journal

The 8-year-old vaccine maker focuses on addressing unmet medical needs.   {iframe}https://www.bizjournals.com/washington/news/2021/03/16/vlp-therapeutics-from-sucampo-founders-raises-16m.html{/iframe}

Read More
Vaccitech Completes $168 Million Series B Financing to Advance Three Clinical Programs Through Phase 2 Results

Vaccitech Completes $168 Million Series B Financing to Advance Three Clinical Programs Through Phase 2 Results

OXFORD, United Kingdom, March 17, 2021 (GLOBE NEWSWIRE) -- Vaccitech Ltd (“Vaccitech”), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel…

Read More
Meet the newest grantees of the Bisciotti Foundation Translational Fund | Hub

Meet the newest grantees of the Bisciotti Foundation Translational Fund | Hub

Four Johns Hopkins professors have received grants for their research through the Bisciotti Foundation Translational Fund. Established with a generous multiyear gift from the…

Read More
How Remote Work Is Reshaping America’s Urban Geography – WSJ

How Remote Work Is Reshaping America’s Urban Geography – WSJ

A year ago, just before the start of pandemic lockdowns, some 10% or less of the U.S. labor force worked remotely full-time. Within a…

Read More
J&J plans to produce up to 3 billion doses of vaccine next year, United States News & Top Stories – The Straits Times

J&J plans to produce up to 3 billion doses of vaccine next year, United States News & Top Stories – The Straits Times

CHICAGO/FRANKFURT • The chief scientist of Johnson & Johnson said the company expects to produce up to three billion doses of its Covid-19 jab…

Read More

After merger, College Park startup IonQ plans to go public with $2 billion valuation

IonQ, a quantum computing startup born in College Park, announced Monday that it would likely soon become the first publicly traded company to specialize…

Read More
Opinion | A Vaccine Maker’s Investment: Emergent BioSolutions Responds – The New York Times

Opinion | A Vaccine Maker’s Investment: Emergent BioSolutions Responds – The New York Times

The past year has been the most important in Emergent BioSolutions’ history. We’ve had the honor of helping our country address Covid-19, manufacturing vaccines…

Read More
VLP Therapeutics names seasoned biotech venture capitalist Miwa Toyoda as CBO | National News | kpvi.com

VLP Therapeutics names seasoned biotech venture capitalist Miwa Toyoda as CBO | National News | kpvi.com

GAITHERSBURG, Md., March 15, 2021 /PRNewswire/ -- US-based biotech company VLP Therapeutics, Inc. (VLPT) announced that it has named Ms. Miwa Toyoda, formerly a…

Read More
Welcome New Members (AMRIE GRAMMER)— Join SIBF

Welcome New Members (AMRIE GRAMMER)— Join SIBF

SIBF welcomes new members.  See the list here. {iframe}http://sibf.org/welcome-new-members{/iframe}

Read More